With tumor progression, circulating neutrophils gradually increase and are converted into tumorigenic tumor-associated neutrophils, characterized by overexpression of CCL12, CXCL2 and Arg1 relative to naive neutrophils20. The gene discussed is CXCL2; the disease is neoplasm.